RSS   Newsletter   Contact   Advertise with us
Post Online Media

Mereo BioPharma Group names Richard CM Jones as CFO

Mereo BioPharma GroupMereo BioPharma Group, a clinical stage biopharmaceutical company, announced that Richard CM Jones has been appointed chief financial officer and will join the board of directors in early 2017.
Mr. Jones joins Mereo from Shield Therapeutics where he has been Chief Financial Officer and Company Secretary.

He was initially appointed as a Non-Executive Director at Shield in 2010 before moving to his current position in 2011 where he had a leading role establishing the finance operations and guiding Shield through its recent IPO.

Prior to this, Mr. Jones had a career in investment banking, holding senior positions at Investec and Brewin Dolphin Securities, where he advised healthcare clients on a wide range of transactions and fundraisings including IPOs and M&A.

He qualified as a Chartered Accountant with PwC in 1991.


 LATEST MOVES FROM United Kingdom 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy